In all, circ_0020123 acted as an oncogene to promote the tumorigenesis of NSCLC via miR-940/KIAA1522 axis, suggesting a potential therapeutic target for NSCLC treatment.
Circ_0020123 promotes NSCLC tumorigenesis via up-regulating KIAA1522 expression through miR-940.